Back to Search
Start Over
Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
- Source :
- The Fly. March 22, 2024
- Publication Year :
- 2024
-
Abstract
- Gilead Sciences (GILD) announced the completion of the previously announced transaction to acquire CymaBay Therapeutics (CBAY) for $4.3B in total equity value. As a result of the completion of the [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.787207154